Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Amling

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
BJU International|September 10, 2008
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital DatabaseRyan S Turley, Martha K Terris, Christopher J Kane, et al.
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
Abdominal Imaging|February 18, 2015
Direct MRI-guided biopsy of the prostate: use of post-biopsy needle track imaging to confirm targetingAlexander J Nicholson, David R Pettersson, Elena K Korngold, et al.
Urology|October 13, 2009
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH databaseSteven L Chang, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|November 7, 2006
Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?Nicholas J Fitzsimons, Joseph C Presti, Christopher J Kane, et al.
BJU International|March 21, 2009
Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomySagar R Shah, Stephen J Freedland, William J Aronson, et al.
The Prostate|September 22, 2012
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH databaseMichael R Abern, William J Aronson, Martha K Terris, et al.
BJU International|November 17, 2009
Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
Cancer|March 21, 2014
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancerMichael R Abern, Martha K Terris, William J Aronson, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
BJU International|September 10, 2008
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital DatabaseRyan S Turley, Martha K Terris, Christopher J Kane, et al.
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|March 18, 2008
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Martha K Terris, et al.
Abdominal Imaging|February 18, 2015
Direct MRI-guided biopsy of the prostate: use of post-biopsy needle track imaging to confirm targetingAlexander J Nicholson, David R Pettersson, Elena K Korngold, et al.
Urology|October 13, 2009
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH databaseSteven L Chang, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|November 7, 2006
Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?Nicholas J Fitzsimons, Joseph C Presti, Christopher J Kane, et al.
BJU International|March 21, 2009
Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomySagar R Shah, Stephen J Freedland, William J Aronson, et al.
The Prostate|September 22, 2012
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH databaseMichael R Abern, William J Aronson, Martha K Terris, et al.
BJU International|November 17, 2009
Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
Cancer|March 21, 2014
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancerMichael R Abern, Martha K Terris, William J Aronson, et al.
Pageof 20